Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data.

IF 7.9 3区 生物学 Q1 MATHEMATICAL & COMPUTATIONAL BIOLOGY
John Zobolas, Anne-Marie George, Alberto López, Sebastian Fischer, Marc Becker, Tero Aittokallio
{"title":"Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data.","authors":"John Zobolas, Anne-Marie George, Alberto López, Sebastian Fischer, Marc Becker, Tero Aittokallio","doi":"10.1186/s13040-026-00546-0","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND: Accurate prediction of patient survival using high-dimensional multi-omics data requires effective feature selection methods that balance predictive performance, sparsity, and stability to enable reproducible and transparent prognostic biomarker discovery. Existing approaches often rely on ad hoc thresholds, limiting their reproducibility and clinical utility. METHODS: We developed a hybrid ensemble feature selection (hEFS) framework that integrates data subsampling with multiple prognostic models, combining embedded and wrapper-based strategies for survival prediction. Features are ranked using a voting-theory-inspired aggregation approach across models and subsamples, while the optimal feature subset is determined via Pareto front optimization, eliminating the need for user-defined thresholds. We benchmarked hEFS against conventional CoxLasso using 100 Monte Carlo cross-validation iterations on multi-omics datasets from three pancreatic ductal adenocarcinoma (PDAC) cohorts, assessing sparsity, stability, redundancy, discrimination, and computational cost. RESULTS: Across all cohorts, hEFS selected substantially fewer and more stable features than CoxLasso (~10 vs. ~60 per modality), with lower variance, while still maintaining comparable discrimination performance with clinical baselines (C-index ~0.54–0.60). Feature redundancy was low, and ensemble subsampling further improved stability. Prognostic performance depended mainly on modality choice, rather than integration model, with gene expression plus clinical variables achieving the highest discrimination power (C-index ~0.64). CONCLUSIONS: hEFS provides a fully automated, interpretable, and reproducible framework for multi-omics biomarker discovery in high-dimensional survival analysis. By producing sparse, yet stable biomarker panels without loss of predictive power, hEFS represents a practical tool for integrative multi-omics modeling and it is openly available in the mlr3fselect R package. </p>","PeriodicalId":48947,"journal":{"name":"Biodata Mining","volume":" ","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13188360/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biodata Mining","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s13040-026-00546-0","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: Accurate prediction of patient survival using high-dimensional multi-omics data requires effective feature selection methods that balance predictive performance, sparsity, and stability to enable reproducible and transparent prognostic biomarker discovery. Existing approaches often rely on ad hoc thresholds, limiting their reproducibility and clinical utility. METHODS: We developed a hybrid ensemble feature selection (hEFS) framework that integrates data subsampling with multiple prognostic models, combining embedded and wrapper-based strategies for survival prediction. Features are ranked using a voting-theory-inspired aggregation approach across models and subsamples, while the optimal feature subset is determined via Pareto front optimization, eliminating the need for user-defined thresholds. We benchmarked hEFS against conventional CoxLasso using 100 Monte Carlo cross-validation iterations on multi-omics datasets from three pancreatic ductal adenocarcinoma (PDAC) cohorts, assessing sparsity, stability, redundancy, discrimination, and computational cost. RESULTS: Across all cohorts, hEFS selected substantially fewer and more stable features than CoxLasso (~10 vs. ~60 per modality), with lower variance, while still maintaining comparable discrimination performance with clinical baselines (C-index ~0.54–0.60). Feature redundancy was low, and ensemble subsampling further improved stability. Prognostic performance depended mainly on modality choice, rather than integration model, with gene expression plus clinical variables achieving the highest discrimination power (C-index ~0.64). CONCLUSIONS: hEFS provides a fully automated, interpretable, and reproducible framework for multi-omics biomarker discovery in high-dimensional survival analysis. By producing sparse, yet stable biomarker panels without loss of predictive power, hEFS represents a practical tool for integrative multi-omics modeling and it is openly available in the mlr3fselect R package.

通过混合集合特征选择和多组学数据发现胰腺癌预后生物标志物。
背景:使用高维多组学数据准确预测患者生存需要有效的特征选择方法,以平衡预测性能、稀疏性和稳定性,从而实现可重复和透明的预后生物标志物发现。现有的方法往往依赖于特别的阈值,限制了它们的可重复性和临床实用性。方法:我们开发了一个混合集成特征选择(hEFS)框架,该框架将数据子采样与多个预后模型相结合,结合了嵌入式和基于包装的生存预测策略。在模型和子样本之间使用投票理论启发的聚合方法对特征进行排序,而通过Pareto front优化确定最优特征子集,从而消除了用户定义阈值的需要。我们对来自三个胰腺导管腺癌(PDAC)队列的多组学数据集进行了100次蒙特卡罗交叉验证迭代,将hEFS与传统的CoxLasso进行了基准测试,评估了稀疏性、稳定性、冗余性、判别性和计算成本。结果:在所有队列中,hEFS比CoxLasso选择了更少、更稳定的特征(每种模式约10 vs 60),方差更低,同时仍保持与临床基线相当的判别性能(c指数约0.54-0.60)。特征冗余度较低,集成子采样进一步提高了稳定性。预后表现主要取决于模式选择,而不是综合模型,基因表达加临床变量的鉴别力最高(c指数~0.64)。结论:hEFS为高维生存分析中的多组学生物标志物发现提供了一个全自动、可解释和可重复的框架。hEFS通过生成稀疏但稳定的生物标志物面板而不损失预测能力,代表了综合多组学建模的实用工具,并且在mlr3fselect R包中公开可用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biodata Mining
Biodata Mining MATHEMATICAL & COMPUTATIONAL BIOLOGY-
CiteScore
7.90
自引率
0.00%
发文量
28
审稿时长
23 weeks
期刊介绍: BioData Mining is an open access, open peer-reviewed journal encompassing research on all aspects of data mining applied to high-dimensional biological and biomedical data, focusing on computational aspects of knowledge discovery from large-scale genetic, transcriptomic, genomic, proteomic, and metabolomic data. Topical areas include, but are not limited to: -Development, evaluation, and application of novel data mining and machine learning algorithms. -Adaptation, evaluation, and application of traditional data mining and machine learning algorithms. -Open-source software for the application of data mining and machine learning algorithms. -Design, development and integration of databases, software and web services for the storage, management, retrieval, and analysis of data from large scale studies. -Pre-processing, post-processing, modeling, and interpretation of data mining and machine learning results for biological interpretation and knowledge discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书